Sangamo BioSciences | SGMO - EPS Earnings Per Share


Sangamo BioSciences reported $-0.18 in EPS Earnings Per Share for its fiscal quarter ending in June of 2024.





Eps Change Date
Alaunos Therapeutics USD -0.52 0.02 Mar/2026
Alnylam Pharmaceuticals USD 1.84 0.15 Jun/2026
Alterity Therapeutics Limited AUD 0 0 Dec/2025
Amgen USD 6.29 1.14 Jun/2026
Bayer EUR 0.95 1.76 Jun/2026
BioCryst Pharmaceuticals USD 0.3 0.87 Jun/2026
Biogen USD 3.6 0.03 Jun/2026
BioMarin Pharmaceutical USD 1.2 0.44 Jun/2026
Cipla INR 9.76 2.9 Jun/2026
Clal Biotechnology ILS -0.04 0.1 Dec/2022
Compugen USD -0.23 0.82 Mar/2026
CSL USD 5.07 3 Dec/2025
Gilead Sciences USD -6.75 8.78 Jun/2026
GlaxoSmithKline GBP 0.51 0.08 Jun/2026
Grifols EUR 0.16 0.02 Mar/2026
Ionis Pharmaceuticals USD -0.69 0.13 Jun/2026
J&J USD 2.9 0.2 Jun/2026
Karyopharm Therapeutics USD -1.02 1.2 Mar/2026
Merck USD -0.13 1.15 Jun/2026
Novartis USD 2.41 0.42 Jun/2026
Omeros USD -1.12 0.37 Jun/2024
Pfizer USD 0.77 0.02 Jun/2026
Roche Holding CHF 10.98 2.61 Jun/2026
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Sanofi EUR 2.09 0.21 Jun/2026
Sarepta Therapeutics USD 0.64 2.52 Jun/2026
Tectonic Therapeutic USD -1.34 0.32 Mar/2026
Ultragenyx Pharmaceutical USD -0.9 0.94 Jun/2026
Vertex Pharmaceuticals USD 4.73 0.26 Jun/2026